Food and Drug Administration

Letting patients access mifepristone through telemedicine does not appear to pose any safety risks, the acting FDA commissioner said.
Medical professionals are urging people not to panic after federal authorities suspended the use of the Johnson & Johnson coronavirus vaccine, citing a very small number of potentially fatal blood clots.
Six recipients in the U.S. out of more than 6.8 million doses developed a rare disorder involving blood clots about two weeks after getting the J&J shot.
The shot was found 100% effective at preventing severe COVID-19, in early findings to be submitted to the Food and Drug Administration.
A new poll found that 42% of Republicans say they probably or definitely will not get the shot, compared with 17% of Democrats — a 25-point split.
The president, who previously expected the U.S. to have enough coronavirus vaccines for all adults by the end of July, urged people to continue to wear masks.
The government regulator approved a third vaccine to battle the coronavirus pandemic in the U.S. — and it's the only one so far to require just one dose.
The FDA's panel of experts will meet Friday to decide whether to approve the coronavirus shot.
A congressional investigation found that numerous products contain "toxic levels" of heavy metals.
The COVID-19 vaccine is less effective than two others, but requires only one dose and can be stored in regular refrigerators.